Keyphrases
Adult Patients
20%
Antifungal Agents
20%
Antifungal Drugs
20%
Azole Therapy
20%
Bloodstream Infection
60%
Brazil
20%
Cancer Patients
40%
Candida Albicans (C. albicans)
60%
Candida Bloodstream Infection
20%
Candida Glabrata
20%
Candida Parapsilosis
20%
Candida Tropicalis
20%
Candidemia
100%
Categorical Variables
20%
Changing Epidemiology
20%
Chemotherapy
20%
Concurrent Malignancy
20%
Critically Ill
20%
Days of Treatment
20%
Descriptive Statistics
20%
Disease Control
20%
Duration of Therapy
20%
Fisher's Exact Test
20%
IDSA Guidelines
20%
Immunosuppressed
20%
International multicenter Study
100%
Intravenous Therapy
40%
Intravenous to Oral Switch
20%
Lebanon
20%
Medical Institutions
20%
Multicenter Retrospective Study
20%
Multivariate Analysis
20%
Negative Culture
20%
Non-neutropenic
20%
Non-neutropenic Patients
100%
Oral Antifungals
20%
Oral Azoles
20%
Oral Therapy
20%
Overall Survival
20%
Resistant Species
20%
Spain
20%
Statistical Programs
20%
Step-down
100%
Time Duration
20%
Treatment Duration
40%
United States
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
50%
Bloodstream Infection
100%
Candida
75%
Candida Albicans
25%
Candida Glabrata
25%
Candida Parapsilosis
25%
Candida Tropicalis
25%
Candidemia
100%
Chemotherapy
25%
Disease
25%
Infection
25%
Intravenous Therapy
50%
Malignant Neoplasm
100%
Overall Survival
25%
Pyrrole
25%
Retrospective Study
25%
Medicine and Dentistry
Antifungal Agent
50%
Blood Culture
25%
Bloodstream Infection
100%
Cancer
25%
Candidemia
100%
Cohort Effect
25%
Disease
25%
Fisher Exact Test
25%
Infection
25%
Intravenous Drug Administration
50%
Malignant Neoplasm
75%
Multivariate Analysis
25%
Overall Survival
25%
Pyrrole
25%
Retrospective Study
25%
Treatment Duration
75%
Nursing and Health Professions
Antifungal Agent
50%
Blood Culture
25%
Bloodstream Infection
100%
Candidemia
100%
Disease Control
25%
Fisher Exact Test
25%
Infection
25%
Intravenous Drug Administration
50%
Malignant Neoplasm
75%
Multivariate Analysis
25%
Overall Survival
25%
Practice Guideline
25%
Pyrrole
25%
Treatment Duration
75%